CAS 1638332-55-4

Otilimab

CAS: 1638332-55-4

Otilimab

Reinheit: ≥95%

Ref: 54-BUP20066

Otilimab

CAS: 1638332-55-4

Otilimab, a humanized monoclonal antibody, blocks GM-CSF to reduce inflammation and may treat severe COVID-19 pneumonia.

Reinheit: > 95%

Farbe und Form: Liquid

Molekulargewicht: 142.22 kDa

Ref: TM-T77125

Otilimab

CAS: 1638332-55-4

Human monoclonal antibody; inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF)

Ref: 3D-CLA1154